CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
News | 06. 24. 2014
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
